Debanjali Ghosh

Statistics

Publications

Citations

283

H-Index

Active since

2018

Affiliations

Washington University in St. Louis(Current)

University of Michigan

University of California, Los Angeles

University of California San Diego

Debanjali Ghosh is an author at Washington University in St. Louis specializing in cetuximab therapy, metastatic squamous cell carcinoma, and cancer pharmacology.

Publications per year

2018–2021

Publications

Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial

Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden et al. · The Lancet Oncology · 2021 · 258 citations · Full text

Medicine, Oncology, Cancer Pharmacology +10

An open label, nonrandomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of cohort 1 interim analysis.

Assuntina G. Sacco, Ruifeng Chen, Debanjali Ghosh et al. · Journal of Clinical Oncology · 2019 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cardiovascular Risk Factor Reduction in First Responders Resulting From an Individualized Lifestyle and Blood Test Program

Rosalynn Gill, H. Robert Superko, Megan M. McCarthy et al. · Journal of Occupational and Environmental Medicine · 2018 · 10 citations · Full text

Medicine, Health Promotion, Preventive Medicine +17

1–3 of 3